文献速递胸部CT

晚期ALK重排非小细胞肺癌的影像学特征与转移模式

Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non-Small Cell Lung Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2019-12-30

该回顾性研究纳入333例晚期非小细胞肺癌患者(ALK+ 119例、EGFR+ 116例、EGFR-/ALK- 98例),由两名放射科医生共同评估原发肿瘤影像特征与转移分布。结果显示ALK+肿瘤更多位于下叶、更少呈亚实性、更少出现空气支气管征,且更常发生远处淋巴结转移和癌性淋巴管炎,但脑转移频率低于EGFR+,骨转移中硬化性骨转移更常见。

要点

  • ALK+晚期NSCLC原发肿瘤多位于下叶(53%),亚实性(1%)和空气支气管征(7%)少见。
  • ALK+肿瘤远处淋巴结转移(20%)和癌性淋巴管炎(37%)频率高于EGFR+及EGFR-/ALK-。
  • ALK+肿瘤脑转移频率(24%)低于EGFR+(41%);骨转移中硬化性骨转移更常见(22%)。

关键影像表现/征象

  • ALK+肿瘤位于下叶的比例为53%,高于EGFR+的34%和EGFR-/ALK-的36%(p < 0.05)。
  • ALK+肿瘤呈亚实性的比例为1%,低于EGFR+的11%和EGFR-/ALK-的8%(p < 0.02)。
  • ALK+肿瘤出现空气支气管征的比例为7%,低于EGFR+的28%和EGFR-/ALK-的29%(p < 0.01)。
  • ALK+肿瘤远处淋巴结转移比例为20%,高于EGFR+的2%和EGFR-/ALK-的9%(p < 0.05)。
  • ALK+肿瘤癌性淋巴管炎比例为37%,高于EGFR+的12%和EGFR-/ALK-的12%(p < 0.01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE.ALK rearrangements are an established targetable oncogenic driver in non-small cell lung cancer (NSCLC). The goal of this study was to determine the imaging features of the primary tumor and metastatic patterns in advanced ALK-rearranged (ALK+) NSCLC that may be different from those in EGFR-mutant (EGFR+) or EGFR/ALK wild-type (EGFR-/ALK-) NSCLC. MATERIALS AND METHODS. Patients with advanced ALK+, EGFR+, or EGFR-/ALK- NSCLC were retrospectively identified. Two radiologists concurrently assessed the imaging features of the primary tumor and the distribution of metastases in these patients. RESULTS. We identified a cohort of 333 patients with metastatic NSCLC (119 ALK+ cases, 116 EGFR+ cases, and 98 EGFR-/ALK- cases). Compared with EGFR+ and EGFR-/ALK- NSCLC, the primary tumor in ALK+ NSCLC was more likely to be located in the lower lobes (53% of ALK+, 34% of EGFR+, and 36% of EGFR-/ALK- tumors; p < 0.05), less likely to be subsolid (1% of ALK+, 11% of EGFR+, and 8% of EGFR-/ALK- tumors; p < 0.02), and less likely to have air bronchograms (7% of ALK+, 28% of EGFR+, and 29% of EGFR-/ALK- tumors; p < 0.01). Compared with EGFR+ and EGFR-/ALK- tumors, ALK+ tumors had higher frequencies of distant nodal metastasis (20% of ALK+ tumors vs 2% of EGFR+ and 9% of EGFR-/ALK- tumors; p < 0.05) and lymphangitic carcinomatosis (37% of ALK+ tumors vs 12% of EGFR+ and 12% of EGFR-/ALK- tumors; p < 0.01), but ALK+ tumors had a lower frequency of brain metastasis compared with EGFR+ tumors (24% vs 41%; p = 0.01). Although there was no statistically significant difference in the frequencies of bone metastasis among the three groups, sclerotic bone metastases were more common in the ALK+ tumors (22% vs 7% of EGFR+ tumors and 6% of EGFR-/ALK- tumors; p < 0.01). CONCLUSION. Advanced ALK+ NSCLC has primary tumor imaging features and patterns of metastasis that are different from those of EGFR+ or EGFR-/ALK- wild type NSCLC at the time of initial presentation.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Mendoza DP, Lin JJ, Rooney MM, et al. Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non-Small Cell Lung Cancer. AJR Am J Roentgenol. 2019. PMID: 31887093. doi:10.2214/AJR.19.21982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。